Best Read Articles on COVID-19 Drug-Related News in 2021

The attention-getting articles about COVID-19 included news about Pfizer's booster and the FDA's rejection Zyesami (aviptadil) for treatment of COVID-19-related respiratory failure.

FDA Rejects EUA for COVID-19 Respiratory Failure Therapy

The FDA didn’t have enough data to assess the risks and benefits of Zyesami.

Read more

Amber Specialty, Hy-Vee to Dispense Regeneron Monoclonal Antibody for COVID-19

Regeneron also announced an expanded contract with the U.S. government for the purchase of additional doses of REGEN-COV.

Read more

Pfizer Submits EUA for COVID-19 Vaccine Booster for All Adults

The FDA had previously issued an EUA for those over the age of 65 and those at high risk for severe COVID-19 or exposure to the virus.

Read more


Concerns About Childhood COVID-19 Vaccines Persist, Despite FDA Committee OK

Some have expressed concerns about the risk of myocarditis and unknown longer-term side effects.

Read more

FDA Issues EUA for Pfizer COVID-19 Vaccine for Children

The dose is one-third of the dose given to people 12 years and older.

Read more